Najoua Ben M'Barek

Title: Najoua Ben M'Barek: Innovator in HIV Research

Introduction

Najoua Ben M'Barek is a prominent inventor based in Marseille, France. She has made significant contributions to the field of HIV research, particularly in developing methods for assessing the sensitivity and resistance of HIV proteases to antiviral agents. With a total of 2 patents, her work is crucial in advancing therapeutic strategies against HIV.

Latest Patents

Her latest patents include a yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent. This innovative method involves amplifying sequences coding for a retrovirus protease, recombining DNA fragments, and culturing transformed yeast cells to perform sensitivity or resistance tests. Another notable patent focuses on determining HIV-2 protease sensitivity or resistance to antivirals using an inducible yeast expression system. This method enhances the understanding of how chemical molecules can inhibit viral proteases, which is vital for developing effective treatments.

Career Highlights

Najoua has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. Her research has been instrumental in the ongoing fight against HIV, contributing to the scientific community's understanding of viral resistance mechanisms.

Collaborations

Throughout her career, Najoua has collaborated with notable scientists, including Pablo Gluschankof and Didier Raoult. These partnerships have enriched her research and expanded the impact of her innovations in the field.

Conclusion

Najoua Ben M'Barek's contributions to HIV research through her innovative patents and collaborations highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in antiviral therapies.